IBDEI06Q ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8775,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8775,1,4,0)
 ;;=4^396.3
 ;;^UTILITY(U,$J,358.3,8775,1,5,0)
 ;;=5^Aortic And Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,8775,2)
 ;;=Aortic and Mitral Insufficiency^269583
 ;;^UTILITY(U,$J,358.3,8776,0)
 ;;=414.3^^69^654^17
 ;;^UTILITY(U,$J,358.3,8776,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8776,1,4,0)
 ;;=4^414.3
 ;;^UTILITY(U,$J,358.3,8776,1,5,0)
 ;;=5^CAD d/t Lipid Rich Plaque
 ;;^UTILITY(U,$J,358.3,8776,2)
 ;;=^336601
 ;;^UTILITY(U,$J,358.3,8777,0)
 ;;=453.9^^69^654^82
 ;;^UTILITY(U,$J,358.3,8777,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8777,1,4,0)
 ;;=4^453.9
 ;;^UTILITY(U,$J,358.3,8777,1,5,0)
 ;;=5^Venous Thrombosis NOS
 ;;^UTILITY(U,$J,358.3,8777,2)
 ;;=^39455
 ;;^UTILITY(U,$J,358.3,8778,0)
 ;;=453.89^^69^654^1
 ;;^UTILITY(U,$J,358.3,8778,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8778,1,4,0)
 ;;=4^453.89
 ;;^UTILITY(U,$J,358.3,8778,1,5,0)
 ;;=5^AC Venous Embolism NEC
 ;;^UTILITY(U,$J,358.3,8778,2)
 ;;=^338259
 ;;^UTILITY(U,$J,358.3,8779,0)
 ;;=453.79^^69^654^27
 ;;^UTILITY(U,$J,358.3,8779,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8779,1,4,0)
 ;;=4^453.79
 ;;^UTILITY(U,$J,358.3,8779,1,5,0)
 ;;=5^Chr Venous Embolism NEC
 ;;^UTILITY(U,$J,358.3,8779,2)
 ;;=^338251
 ;;^UTILITY(U,$J,358.3,8780,0)
 ;;=425.11^^69^654^55
 ;;^UTILITY(U,$J,358.3,8780,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8780,1,4,0)
 ;;=4^425.11
 ;;^UTILITY(U,$J,358.3,8780,1,5,0)
 ;;=5^Hypertrophic Subaortic Stenosis
 ;;^UTILITY(U,$J,358.3,8780,2)
 ;;=^340520
 ;;^UTILITY(U,$J,358.3,8781,0)
 ;;=425.18^^69^654^61
 ;;^UTILITY(U,$J,358.3,8781,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8781,1,4,0)
 ;;=4^425.18
 ;;^UTILITY(U,$J,358.3,8781,1,5,0)
 ;;=5^Oth Hypertrophic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,8781,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,8782,0)
 ;;=V12.55^^69^654^50
 ;;^UTILITY(U,$J,358.3,8782,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8782,1,4,0)
 ;;=4^V12.55
 ;;^UTILITY(U,$J,358.3,8782,1,5,0)
 ;;=5^Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,8782,2)
 ;;=^340615
 ;;^UTILITY(U,$J,358.3,8783,0)
 ;;=414.4^^69^654^16
 ;;^UTILITY(U,$J,358.3,8783,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8783,1,4,0)
 ;;=4^414.4
 ;;^UTILITY(U,$J,358.3,8783,1,5,0)
 ;;=5^CAD d/t Calc Coronary Lesion
 ;;^UTILITY(U,$J,358.3,8783,2)
 ;;=^340518
 ;;^UTILITY(U,$J,358.3,8784,0)
 ;;=271.3^^69^655^17
 ;;^UTILITY(U,$J,358.3,8784,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8784,1,4,0)
 ;;=4^271.3
 ;;^UTILITY(U,$J,358.3,8784,1,5,0)
 ;;=5^Glucose Intolerance
 ;;^UTILITY(U,$J,358.3,8784,2)
 ;;=^64790
 ;;^UTILITY(U,$J,358.3,8785,0)
 ;;=611.1^^69^655^22
 ;;^UTILITY(U,$J,358.3,8785,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8785,1,4,0)
 ;;=4^611.1
 ;;^UTILITY(U,$J,358.3,8785,1,5,0)
 ;;=5^Gynecomastia
 ;;^UTILITY(U,$J,358.3,8785,2)
 ;;=^60454
 ;;^UTILITY(U,$J,358.3,8786,0)
 ;;=704.1^^69^655^23
 ;;^UTILITY(U,$J,358.3,8786,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8786,1,4,0)
 ;;=4^704.1
 ;;^UTILITY(U,$J,358.3,8786,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,8786,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,8787,0)
 ;;=251.2^^69^655^36
 ;;^UTILITY(U,$J,358.3,8787,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8787,1,4,0)
 ;;=4^251.2
 ;;^UTILITY(U,$J,358.3,8787,1,5,0)
 ;;=5^Hypoglycemia Nos
 ;;^UTILITY(U,$J,358.3,8787,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,8788,0)
 ;;=257.2^^69^655^37
 ;;^UTILITY(U,$J,358.3,8788,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8788,1,4,0)
 ;;=4^257.2
 ;;^UTILITY(U,$J,358.3,8788,1,5,0)
 ;;=5^Hypogonadism,Male
 ;;^UTILITY(U,$J,358.3,8788,2)
 ;;=^88213
 ;;^UTILITY(U,$J,358.3,8789,0)
 ;;=253.2^^69^655^41
 ;;^UTILITY(U,$J,358.3,8789,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8789,1,4,0)
 ;;=4^253.2
 ;;^UTILITY(U,$J,358.3,8789,1,5,0)
 ;;=5^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,8789,2)
 ;;=^60686
 ;;^UTILITY(U,$J,358.3,8790,0)
 ;;=733.00^^69^655^52
 ;;^UTILITY(U,$J,358.3,8790,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8790,1,4,0)
 ;;=4^733.00
 ;;^UTILITY(U,$J,358.3,8790,1,5,0)
 ;;=5^Osteoporosis Nos
 ;;^UTILITY(U,$J,358.3,8790,2)
 ;;=^87159
 ;;^UTILITY(U,$J,358.3,8791,0)
 ;;=278.00^^69^655^48
 ;;^UTILITY(U,$J,358.3,8791,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8791,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,8791,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,8791,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,8792,0)
 ;;=278.01^^69^655^47
 ;;^UTILITY(U,$J,358.3,8792,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8792,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,8792,1,5,0)
 ;;=5^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,8792,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,8793,0)
 ;;=250.80^^69^655^15
 ;;^UTILITY(U,$J,358.3,8793,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8793,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,8793,1,5,0)
 ;;=5^DM Type II W/ LE Ulcer
 ;;^UTILITY(U,$J,358.3,8793,2)
 ;;=DM Type II with LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,8794,0)
 ;;=250.00^^69^655^9
 ;;^UTILITY(U,$J,358.3,8794,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8794,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,8794,1,5,0)
 ;;=5^DM Type II  W/O Complications
 ;;^UTILITY(U,$J,358.3,8794,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,8795,0)
 ;;=250.40^^69^655^11
 ;;^UTILITY(U,$J,358.3,8795,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8795,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,8795,1,5,0)
 ;;=5^DM Type II W/ Nephropathy
 ;;^UTILITY(U,$J,358.3,8795,2)
 ;;=^267837^583.81
 ;;^UTILITY(U,$J,358.3,8796,0)
 ;;=250.50^^69^655^14
 ;;^UTILITY(U,$J,358.3,8796,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8796,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,8796,1,5,0)
 ;;=5^DM Type II W/ PDR
 ;;^UTILITY(U,$J,358.3,8796,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,8797,0)
 ;;=250.60^^69^655^12
 ;;^UTILITY(U,$J,358.3,8797,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8797,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,8797,1,5,0)
 ;;=5^DM Type II W/ Neuropathy
 ;;^UTILITY(U,$J,358.3,8797,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,8798,0)
 ;;=250.70^^69^655^13
 ;;^UTILITY(U,$J,358.3,8798,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8798,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,8798,1,5,0)
 ;;=5^DM Type II W/ Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,8798,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,8799,0)
 ;;=250.01^^69^655^8
 ;;^UTILITY(U,$J,358.3,8799,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8799,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,8799,1,5,0)
 ;;=5^DM Type I  W/O Complications
 ;;^UTILITY(U,$J,358.3,8799,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,8800,0)
 ;;=272.0^^69^655^28
 ;;^UTILITY(U,$J,358.3,8800,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8800,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,8800,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,8800,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,8801,0)
 ;;=272.1^^69^655^33
 ;;^UTILITY(U,$J,358.3,8801,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8801,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,8801,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,8801,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,8802,0)
 ;;=272.2^^69^655^30
 ;;^UTILITY(U,$J,358.3,8802,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8802,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,8802,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,8802,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,8803,0)
 ;;=275.42^^69^655^27
 ;;^UTILITY(U,$J,358.3,8803,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8803,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,8803,1,5,0)
 ;;=5^Hypercalcaemia
 ;;^UTILITY(U,$J,358.3,8803,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,8804,0)
 ;;=275.41^^69^655^35
 ;;^UTILITY(U,$J,358.3,8804,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8804,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,8804,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,8804,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,8805,0)
 ;;=276.7^^69^655^29
 ;;^UTILITY(U,$J,358.3,8805,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8805,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,8805,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,8805,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,8806,0)
 ;;=275.2^^69^655^25
 ;;^UTILITY(U,$J,358.3,8806,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8806,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,8806,1,5,0)
 ;;=5^Hyper or Hypomagnesaemia
 ;;^UTILITY(U,$J,358.3,8806,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,8807,0)
 ;;=276.0^^69^655^31
 ;;^UTILITY(U,$J,358.3,8807,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8807,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,8807,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,8807,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,8808,0)
 ;;=276.1^^69^655^38
 ;;^UTILITY(U,$J,358.3,8808,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8808,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,8808,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,8808,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,8809,0)
 ;;=275.3^^69^655^26
 ;;^UTILITY(U,$J,358.3,8809,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8809,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,8809,1,5,0)
 ;;=5^Hyper or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,8809,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,8810,0)
 ;;=240.0^^69^655^20
 ;;^UTILITY(U,$J,358.3,8810,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8810,1,4,0)
 ;;=4^240.0
 ;;^UTILITY(U,$J,358.3,8810,1,5,0)
 ;;=5^Goiter, Simple
 ;;^UTILITY(U,$J,358.3,8810,2)
 ;;=^259806
 ;;^UTILITY(U,$J,358.3,8811,0)
 ;;=241.1^^69^655^19
 ;;^UTILITY(U,$J,358.3,8811,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8811,1,4,0)
 ;;=4^241.1
 ;;^UTILITY(U,$J,358.3,8811,1,5,0)
 ;;=5^Goiter, Nontox, Multinod
 ;;^UTILITY(U,$J,358.3,8811,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,8812,0)
 ;;=241.0^^69^655^59
 ;;^UTILITY(U,$J,358.3,8812,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8812,1,4,0)
 ;;=4^241.0
 ;;^UTILITY(U,$J,358.3,8812,1,5,0)
 ;;=5^Thyroid Nodule, Nontoxic
 ;;^UTILITY(U,$J,358.3,8812,2)
 ;;=^83865
